Comments on: FDA’s drug-monitoring process flunks another test /edsblog/fdas-drug-monitoring-process-flunks-another-test/ Helping Americans get safe access to affordable medications. Mon, 06 May 2013 18:36:51 +0000 hourly 1 http://wordpress.org/?v=3.5.1 By: eDrugSearch Blog » Blog Archive » Note to FDA: Older diabetes drugs are cheaper, as effective and have fewer side effects than newer ones /edsblog/fdas-drug-monitoring-process-flunks-another-test/comment-page-1/#comment-55961 eDrugSearch Blog » Blog Archive » Note to FDA: Older diabetes drugs are cheaper, as effective and have fewer side effects than newer ones Fri, 20 Jul 2007 12:28:59 +0000 /edsblog/fdas-drug-monitoring-process-flunks-another-test/#comment-55961 [...] Note to FDA: Older diabetes drugs are cheaper, as effective and have fewer side effects than newer ones It appears someone finally decided to take a look at the effectiveness and benefits of older diabetes drugs (such as metformin) compared with newer, more expensive ones (such as Avandia). Dr. Shari Bolen of Johns Hopkins University studied various medical databases and found 216 relevant studies and two systematic reviews. According to Reuters: Older drugs controlled blood sugar levels about as well as the thiazolidinediones [Avandia] did. There were some differences, however, in other effects. [...]

]]>